Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 22:13:623-632.
doi: 10.2147/RMHP.S231075. eCollection 2020.

Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment

Affiliations

Development and Evaluation of an Educational Program for Community Pharmacists on Cardiovascular Risk Assessment

Monica Zolezzi et al. Risk Manag Healthc Policy. .

Abstract

Purpose: Cardiovascular disease (CVD) risk assessment is an important strategy for the prevention of CVD. Pharmacists play an important role in CVD risk assessment and management (CVDRAM). Our previous study identified gaps in knowledge among community pharmacists for the provision of CVDRAM services as assessed through patient simulation. Therefore, our objectives were: a) to develop and evaluate an educational program on CVD risk assessment for community pharmacists, b) to assess the knowledge and skills of participating pharmacists in assessing and managing CVD risk before and after enrolling in the educational program and c) to explore pharmacists' satisfaction and perceived effectiveness of the educational program.

Methods: Using a blended learning instructional approach, the educational program for a subset of 25 community pharmacists recruited from our previous study consisted of two face-to-face workshops, and an online 5-module course on CVD risk factors such as hyperlipidemia, hypertension, diabetes, obesity, and smoking cessation based on principles of adult learning. A repeated measures study design was utilized by measuring participants' knowledge on pre- and post-questionnaires and an objective structured clinical examination (OSCE) at the conclusion of the educational program was also used to assess its impact on the knowledge and skills of community pharmacists in the provision of CVD risk assessment and management (CVDRAM) services. The knowledge questionnaire was completed by 23 pharmacists while the OSCE was completed by 8 pharmacists. In addition, a survey assessed the pharmacists' level of satisfaction with the educational program.

Results: At the conclusion of the educational program, the participating pharmacists achieved knowledge and skills for the provision of CVDRAM services. Knowledge scores in relation to CVDRAM significantly improved after the educational program [out of a maximum of 20 points, the median (interquartile range) = 9 (7-9) at pre- vs 12 (12-13) at post-educational program], p<0.001. On the OSCE, the median (interquartile range) scores for Stations 1 and 2 were 66 (63-71) and 71 (67-76), respectively. Out of the 21 pharmacists that completed the satisfaction survey, 71% were very satisfied and 29% were satisfied with the educational program.

Conclusion: The educational program improved pharmacists' knowledge and skills for the provision of CVDRAM services.

Keywords: cardiovascular disease risk assessment; community pharmacists; educational program; evaluation; pharmacists’ preparedness.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Screenshot of web-based course builder using Articulate 360® software. Representative screenshot of a course module developed using the Articulate 360® software is shown.
Figure 2
Figure 2
Participants’ satisfaction with the educational program. Participants were administered a satisfaction survey at the conclusion of the educational program that was graded on a 5-point scale (very satisfied, satisfied, neutral, dissatisfied and very dissatisfied). The height of the bars represents the number of respondents providing a given rating.

Similar articles

Cited by

References

    1. WHO. Cardiovascular diseases. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases...). Accessed February17, 2019.
    1. WHO. Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk. 2007. Available from: http://www.who.int/cardiovascular_diseases/guidelines/PocketGL.ENGLISH.A.... Accessed September15, 2018.
    1. Labarthe DR, Dunbar SB. Global cardiovascular health promotion and disease prevention: 2011 and beyond. Circulation. 2012;125(21):2667–2676. doi:10.1161/CIRCULATIONAHA.111.087726 - DOI - PubMed
    1. Grundy SM, Pasternak R, Greenland P, Smith S Jr, Fuster V. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 1999;100(13):1481–1492. doi:10.1161/01.CIR.100.13.1481 - DOI - PubMed
    1. Cardiovascular disease risk assessment for primary prevention: our approach. 2019. Available from: https://www.uptodate.com/contents/cardiovascular-disease-risk-assessment.... Accessed February10, 2019.